Bautista, Remejane S.
HRN: 28-68-30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFUROXIME 750MG (VIAL)
03/08/2026
03/15/2026
IV
750mg
Q8h
Uti
Checking Initial Appropriateness
03/11/2026
CEFUROXIME 750MG (VIAL)
03/11/2026
03/17/2026
IV
750
Q8
UTI
Checking Initial Appropriateness